Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 1,343

Document Document Title
WO/1991/010655A1
The invention relates to partially novel metal complexes, salts and double salts of 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane compounds of formula (I), wherein Q1 and Q2 mean hydrogen or a group of formula (III), in the groups of form...  
WO/1991/009863A1
Organophosphorus-substituted oxadiazines (I) are disclosed which exhibit insecticidal, acaricidal and nematicidal activity, as well as compositions including such compounds, and methods for controlling insects, acarids or nematodes emplo...  
WO/1990/014343A1
Pharmaceutical composition for decorporating radioactive isotopes from living organisms comprising as active agent a product prepared by reacting 1,4,10,17-tetraoxa-7,16-diazacyclooctadecane with 2-bromomalonic acid disodium salt.  
WO1990007111A3  
WO/1990/007111A2
A molecular model of the interaction of various non beta-lactam antibiotics with the active site of a penicillin receptor has been developed so that it is now possible to predict the ''fit'' and ''reactivity'' of potential antibacterial ...  
WO/1990/003975A1
A process is provided for the preparation of Mn(II) chelates for use as contrast agents in magnetic resonance imaging, said process comprising reacting insoluble manganese (II) oxide with an aqueous suspension comprising a molar equivale...  
WO/1989/010752A1
A retroviral protease inhibiting compound of formula (I) or a pharmaceutically acceptable salt, prodrug or ester thereof.  
WO/1989/000557A1
There are provided chelating agents particularly useful for the preparations of diagnostic and therapeutic agents for magnetic resonance imaging, scintigraphy, ultrasound imaging, radiotherapy and heavy metal detoxification, said agents ...  
WO/1987/005030A1
A conjugate compound has the structure (I), wherein R1 is -(CH2)p-R6-(CH2)q- where p and q are the same or different and are 0, 1 or 2, and -R6- is -(CH2)n-, where n is 0 or 1, -NH-, -O-, -S- or (II), R1 optionally being alkyl substitute...  
WO/1985/003078A1
Platinum and crown ether complexes having the general formula (I), wherein C is a mono- or bicyclic crown ether, A is ammonia or a mono- or di-Cl-C4-alkylamine or an amine function contained in the crown ether and X is halogen or the ani...  
WO/1982/004252A1
N-hydroxyethylated macrocyclic polyamines of the formula (FORMULA) in which X is O or N(CH2CH2OH), and each of Y1 and Y2, which are equal or different, are (FORMULA) with the proviso that X is different from N (CH2CH2OH) when both Y1 and...  
WO/1982/004253A1
New aza-crown-ethers having the general formula (FORMULA) in which a) X is oxygen and R is hydrogen, alkyl, aralkyl, aryl, alkoxyalkyl, hydroxyalkyl, alkoxycarbonylalkyl, carbamoylalkyl, nitrophenyldiazophenyl or (FORMULA) in which n is ...  
WO/1981/002420A1
Betaine is recovered from natural sources such as beet molasses, rest molasses and vinasse by diluting the molasses to 25-50% solids, introducing the molasses to the top of a chromatographic column containing a salt of polystyrene sulfon...  
JP6586416B2  
JP6581559B2  
JP6475301B2  
JP6464970B2  
JP6461113B2  
JP2018531894A
The present invention is the method of denaturing isocyanate which makes at least one sort of organic isocyanate which has more than one NCO functional value oligomer-ize under at least one sort of existence of a catalyst, A catalyst con...  
JP2018521972A
The present invention provides the Urea compound which has Formyl peptide receptor Mr. 1 (it may translate into FPRL1 hereafter) agonistic effect or its salt permitted pharmacologically, the medical-supplies constituent containing it, an...  
JP2018517762A
The present invention relates to antibody - or a peptide drug thing conjugate compound in which a covalent bond is carried out by disintegration linker which one or more crypto Ficin derivatives (large annular Depsi peptide) combine with...  
JP2018517696A
It is the process of preparing (E) - (5, 6-dihydro1, 4, 2-dioxazine 3- Il ) (2-hydroxyphenyl) meta-non O-methyl oxime, and is under existence of (i) metal Alkoxide , At least one nitrite salt chosen from nitrous acid n-butyl and nitrous ...  
JP2018513118A
本発明は、式(I)で示される環式化合物、 ならびにプログラム細胞死1(PD−1)シ グナル伝達経路を阻害するため、および/ま たはPD−1、PD−L1もしくはPD...  
JP2018502911A
The medicine constituent in which the present invention contains a membrane permeability creatine prodrug and a membrane permeability creatine prodrug, And the therapeutic method of diseases, such as ischemia, heart failure and a neurode...  
JP2016536372A5  
JP6177768B2  
JP6174600B2  
JP6148006B2  
JP6111276B2  
JP2017052729A
To provide a method for manufacturing an oxaziridine compound used for various reactions as a variety of uses, such as oxidant, which is safe and simple and is capable of efficiently manufacturing while eliminating contamination of impur...  
JP2017031058A
To provide a novel cyclic depsipeptide derivative and a pest control agent comprising the same.The present invention provides a cyclic depsipeptide derivative represented by formula (1) or a stereoisomer thereof, and a pest control agent...  
JPWO2014119636A1
Medicine containing a new molecular entity and it which have an antiviral action, especially HIV duplicate prevention activity, especially an anti-HIV drug are provided. Conversion into 1a formula -- inside -- a ring -- A -- substitution...  
JP6068505B2  
JP6058482B2  
JP2015503542A5  
JP2012525357A5  
JP2016536372A
The present invention provides a method of using a compound and its medicine constituent, or a tablet of a useful new creatine analog and the present invention, and treating and preventing creatine deficiency, in order to treat arbitrary...  
JP2016529240A
The present invention is a method for producing the polyisocyanate containing an imino oxadiadine dione machine, At least one mono- Merrick * and/or Tori * isocyanate, a) At least one catalyst, at least one additive agent (A) which has l...  
JP2016522236A
The present invention is formula 8:It is related with the medicine constituent for using it as Chitinase inhibitor in a of size annular Amidino urea derivative, its preparing method and its use, especially the medical treatment of a myco...  
JP2016521699A
The present invention relates to the large annular urea derivative (the bottom defines R1, R2, R3, V, and Y in a formula) of formula (I). The compound of formula I is inhibitor of enzyme TAFIa (activated thrombin activation Fibrinolysis ...  
JP5856924B2  
JPWO2013161851A
The present invention relates to a benzamide derivative denoted by formula (I), or its salt permitted in medicine.  
JPWO2013161851A1
本発明は、式(I)で表わされるベンズアミ ド誘導体またはその医薬的に許容される塩に 関する。  
JP5826150B2  
JP5826149B2  
JP5806926B2  
JP5782586B2  
JP5779787B2  
JP2015147792A
To provide novel spiro condensed heterocyclic compound having β-secretase enzyme (BACE) inhibitory activity and being effective in treatment of BACE mediated disorders such as Alzheimer's disease, cognitive impairment, Down's Syndrome, ...  
JP5730835B2  

Matches 401 - 450 out of 1,343